NCT05010005 2026-04-09A Study of Ruxolitinib and Duvelisib in People With LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting70 enrolled
NCT04803201 2026-04-02Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaAlliance for Clinical Trials in OncologyPhase 2 Suspended170 enrolled